We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Most Claims Survive In Royalty Spat Over HPV Drug

Law360 (May 26, 2009, 12:00 AM EDT) -- A Delaware judge has let the majority of claims stand in a breach of contract suit brought against MedImmune Inc. and Glaxo Group Ltd. over human papillomavirus vaccine Cervarix, but has...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.